Artwork

Контент предоставлен Down There Aware. Весь контент подкастов, включая эпизоды, графику и описания подкастов, загружается и предоставляется непосредственно компанией Down There Aware или ее партнером по платформе подкастов. Если вы считаете, что кто-то использует вашу работу, защищенную авторским правом, без вашего разрешения, вы можете выполнить процедуру, описанную здесь https://ru.player.fm/legal.
Player FM - приложение для подкастов
Работайте офлайн с приложением Player FM !

A Conversation with Travera

56:59
 
Поделиться
 

Manage episode 371302390 series 3237644
Контент предоставлен Down There Aware. Весь контент подкастов, включая эпизоды, графику и описания подкастов, загружается и предоставляется непосредственно компанией Down There Aware или ее партнером по платформе подкастов. Если вы считаете, что кто-то использует вашу работу, защищенную авторским правом, без вашего разрешения, вы можете выполнить процедуру, описанную здесь https://ru.player.fm/legal.

This week Mary and Alex speak with Cliff Reed, Founding CEO, and Dennis Watson, VP Business Development, of Travera, a company specializing in new technology enhancing the landscape of late stage cancer treatment.

Listen on our website, www.downthereaware.com/podcast, or wherever you get your podcasts.

#Podcast #Spotify #Anchor #research #advocacy #cancer #Travera #genomics #DNA #MIT #FDA #CLIA #LDT #cancerresearch #technology #cancertechnology #innovation #groundbreaking #latestagecancer #stage4cancer #uterinecancer #ovariancancer #leukemia

Stay Connected

Email Us: downthereaware@gmail.com

Instagram:@downthereaware

Facebook: Down There Aware

Twitter: @downthereaware

Pinterest: Down There Aware

TikTok: Down There Aware

Episode Links

TRAVERA

Episode Highlights

  • Intro [0:13]

  • Welcome Back! [1:25]

  • Guest introductions [1:44]

  • M.I.T. technology [3:42]

  • Genomics and DNA sequencing [3:58]

  • Limited patients [4:05]

  • New measurement tool [4:48]

  • MIT/Dana Farber Cancer Institute partnership [5:32]

  • Infectious disease comparison [5:48]

  • Multiple Myeloma [6:38]

  • “Cheat code” [7:30]

  • Commercial launch [9:09]

  • Test offered for free [10:15]

  • Working with physicians [10:55]

  • Trial and error process for patient [13:20]

  • Advocacy groups [15:25]

  • Patient profile [16:01]

  • Cancer mutation [17:57]

  • Access to live cancer cells [18:38]

  • Quick turn-around for results[21:30]

  • No additional burden on patient [23:35]

  • Early stage testing and limited data [24:28]

  • Predictive accuracy over 80% [25:12]

  • Late stage cancer patients [26:25]

  • Response from oncology community [28:00]

  • Difference in this x vivo test [29:25}

  • No financial risk [30:00]

  • Great value to research and future patients [31:57]

  • MIT intent [34:57]

  • Great creative minds in scientific research [36:15]

  • Future of Travera’s efforts [36:55]

  • The bigger plan [39:01]

  • FDA approval/CLIA certification [40:05]

  • Laboratory Developed Test (LDT) [40:21]

  • Potential to greatly benefit newly diagnosed patients[41:49]

  • Microchip specs [43:45]

  • Physics vs biochemistry[46:20]

  • Simple comparison to a diving board [47:05]

  • Speed and logic [49:47]

  • If someone is listening today and is interested [51:30]

  • dwatson@travera.com [52:23]

  • PHI and HIPAA [53:35]

  • Hearing from those who know best [55:03]

  • Thanks for listening! [56:19]

Stay Connected

Podcast, Spotify, Anchor, research, advocacy, cancer, Travera, genomics, DNA, MIT, FDA, CLIA, LDT, cancer research, technology, cancer technology, innovation, groundbreaking, late-stage cancer, stage 4 cancer, uterine cancer, ovarian cancer, leukemia

  continue reading

127 эпизодов

Artwork
iconПоделиться
 
Manage episode 371302390 series 3237644
Контент предоставлен Down There Aware. Весь контент подкастов, включая эпизоды, графику и описания подкастов, загружается и предоставляется непосредственно компанией Down There Aware или ее партнером по платформе подкастов. Если вы считаете, что кто-то использует вашу работу, защищенную авторским правом, без вашего разрешения, вы можете выполнить процедуру, описанную здесь https://ru.player.fm/legal.

This week Mary and Alex speak with Cliff Reed, Founding CEO, and Dennis Watson, VP Business Development, of Travera, a company specializing in new technology enhancing the landscape of late stage cancer treatment.

Listen on our website, www.downthereaware.com/podcast, or wherever you get your podcasts.

#Podcast #Spotify #Anchor #research #advocacy #cancer #Travera #genomics #DNA #MIT #FDA #CLIA #LDT #cancerresearch #technology #cancertechnology #innovation #groundbreaking #latestagecancer #stage4cancer #uterinecancer #ovariancancer #leukemia

Stay Connected

Email Us: downthereaware@gmail.com

Instagram:@downthereaware

Facebook: Down There Aware

Twitter: @downthereaware

Pinterest: Down There Aware

TikTok: Down There Aware

Episode Links

TRAVERA

Episode Highlights

  • Intro [0:13]

  • Welcome Back! [1:25]

  • Guest introductions [1:44]

  • M.I.T. technology [3:42]

  • Genomics and DNA sequencing [3:58]

  • Limited patients [4:05]

  • New measurement tool [4:48]

  • MIT/Dana Farber Cancer Institute partnership [5:32]

  • Infectious disease comparison [5:48]

  • Multiple Myeloma [6:38]

  • “Cheat code” [7:30]

  • Commercial launch [9:09]

  • Test offered for free [10:15]

  • Working with physicians [10:55]

  • Trial and error process for patient [13:20]

  • Advocacy groups [15:25]

  • Patient profile [16:01]

  • Cancer mutation [17:57]

  • Access to live cancer cells [18:38]

  • Quick turn-around for results[21:30]

  • No additional burden on patient [23:35]

  • Early stage testing and limited data [24:28]

  • Predictive accuracy over 80% [25:12]

  • Late stage cancer patients [26:25]

  • Response from oncology community [28:00]

  • Difference in this x vivo test [29:25}

  • No financial risk [30:00]

  • Great value to research and future patients [31:57]

  • MIT intent [34:57]

  • Great creative minds in scientific research [36:15]

  • Future of Travera’s efforts [36:55]

  • The bigger plan [39:01]

  • FDA approval/CLIA certification [40:05]

  • Laboratory Developed Test (LDT) [40:21]

  • Potential to greatly benefit newly diagnosed patients[41:49]

  • Microchip specs [43:45]

  • Physics vs biochemistry[46:20]

  • Simple comparison to a diving board [47:05]

  • Speed and logic [49:47]

  • If someone is listening today and is interested [51:30]

  • dwatson@travera.com [52:23]

  • PHI and HIPAA [53:35]

  • Hearing from those who know best [55:03]

  • Thanks for listening! [56:19]

Stay Connected

Podcast, Spotify, Anchor, research, advocacy, cancer, Travera, genomics, DNA, MIT, FDA, CLIA, LDT, cancer research, technology, cancer technology, innovation, groundbreaking, late-stage cancer, stage 4 cancer, uterine cancer, ovarian cancer, leukemia

  continue reading

127 эпизодов

Tất cả các tập

×
 
Loading …

Добро пожаловать в Player FM!

Player FM сканирует Интернет в поисках высококачественных подкастов, чтобы вы могли наслаждаться ими прямо сейчас. Это лучшее приложение для подкастов, которое работает на Android, iPhone и веб-странице. Зарегистрируйтесь, чтобы синхронизировать подписки на разных устройствах.

 

Краткое руководство